{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T20:45:45Z","timestamp":1769978745209,"version":"3.49.0"},"reference-count":21,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2020,1,17]],"date-time":"2020-01-17T00:00:00Z","timestamp":1579219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Children born prematurely have been treated with growth hormone (GH), and a significant improvement in height during the first years of treatment has been described.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the influence of prematurity on near-adult height (NAH) after GH treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>KIGS (Pfizer International Growth Database) was queried for children born preterm treated with GH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>KIGS database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>A total of 586 children short in stature born preterm with various GH status and with available gestational age (GA), birth weight, and NAH, all treated with GH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Intervention<\/jats:title>\n                  <jats:p>GH treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measure<\/jats:title>\n                  <jats:p>NAH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Values were expressed as median. From the 586 children included, 482 born appropriate for GA (AGA; median age 8.26 years) and 104 born small for gestational age (SGA) (median age 8.54 years); 66.6% of preterm AGA had GH peak\u2005&amp;lt;\u20057 \u00b5g\/L during a provocation test, whereas only 8.6% of preterm SGA. Change in height standard deviation scores (SDS) from GH start to NAH after 8.04 years of GH treatment was 1.82 in preterm AGA. Respective values were 7.08 years and 1.08 SDS for preterm SGA (P\u2005&amp;lt;\u20050.001); 57% of the variability of the growth response to NAH could be explained, and the distance to parental height was the strongest predictor. No significant changes in height SDS were observed from puberty start to NAH. No correlation was found with GA. GH treatment was well tolerated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>GH treatment resulted in significant improvement in height in children born preterm, particularly during prepubertal years and for those with GH deficiency. The degree of prematurity did not influence the growth response.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa203","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T12:40:15Z","timestamp":1591015215000},"page":"e2457-e2463","source":"Crossref","is-referenced-by-count":9,"title":["Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely\u2014Data From KIGS"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-0715","authenticated-orcid":false,"given":"Margaret C S","family":"Boguszewski","sequence":"first","affiliation":[{"name":"Department o \u00a0f Pediatrics, Federal University of Paran\u00e1, Curitiba, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Pfizer Inc. New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Lindberg","sequence":"additional","affiliation":[{"name":"Pfizer Inc. New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jovanna","family":"Dahlgren","sequence":"additional","affiliation":[{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Dept of Endocrinology, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferah","family":"Aydin","sequence":"additional","affiliation":[{"name":"Pfizer Health AB, Sollentuna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Camacho-H\u00fcbner","sequence":"additional","affiliation":[{"name":"Pfizer Inc. New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita C S","family":"Hokken-Koelega","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center \/ Sophia Children\u2019s Hospital, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2020,1,17]]},"reference":[{"key":"2021122116304782200_CIT0001","doi-asserted-by":"crossref","first-page":"S2:1","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"issue":"2","key":"2021122116304782200_CIT0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.siny.2015.12.011","article-title":"The epidemiology, etiology, and costs of preterm birth","volume":"21","author":"Frey","year":"2016","journal-title":"Semin Fetal Neonatal Med."},{"issue":"3","key":"2021122116304782200_CIT0003","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-16-0482","article-title":"Management of endocrine disease: growth and growth hormone therapy in short children born preterm","volume":"176","author":"Boguszewski","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021122116304782200_CIT0004","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/00006450-199508000-00022","article-title":"Children born small for gestational age: do they catch up?","volume":"38","author":"Hokken-Koelega","year":"1995","journal-title":"Pediatr Res."},{"issue":"6","key":"2021122116304782200_CIT0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/apa.13350","article-title":"Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development","volume":"105","author":"Hellstr\u00f6m","year":"2016","journal-title":"Acta Paediatr."},{"issue":"2","key":"2021122116304782200_CIT0006","first-page":"240","article-title":"National Cooperative Growth Study: 25 years of growth hormone data, insights, and lessons for future registries","volume":"16","author":"Bell","year":"2018","journal-title":"Pediatr Endocrinol Rev."},{"issue":"5","key":"2021122116304782200_CIT0007","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrendo.2018.22","article-title":"Growth hormone \u2013 past, present and future","volume":"14","author":"Ranke","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"6","key":"2021122116304782200_CIT0008","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2010-1829","article-title":"Growth hormone treatment in short children born prematurely\u2013data from KIGS","volume":"96","author":"Boguszewski","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122116304782200_CIT0009","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1210\/jc.2005-2284","article-title":"Effect of growth hormone (GH) treatment on the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database","volume":"91","author":"Reiter","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021122116304782200_CIT0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1507\/endocrj.EJ17-0063","article-title":"The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s","volume":"64","author":"Isojima","year":"2017","journal-title":"Endocr J."},{"key":"2021122116304782200_CIT0011","first-page":"7","article-title":"Models predicting the growth response to growth hormone treatment in short children independent of GH status, birth size and gestational age","volume":"12","author":"Dahlgren","year":"2007","journal-title":"BMC Med Inform Decis Mak"},{"key":"2021122116304782200_CIT0012","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000101495","article-title":"Diagnosis of children with short stature: insights from KIGS","volume-title":"Growth Hormone Therapy in Pediatrics \u2013 20 Years of KIGS. Basel","author":"Fujieda","year":"2007"},{"key":"2021122116304782200_CIT0013","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1651-2227.1991.tb11945.x","article-title":"An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981)","volume":"80","author":"Niklasson","year":"2007","journal-title":"Acta Paediatr Scand"},{"key":"2021122116304782200_CIT0014","first-page":"1","article-title":"Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development","volume":"52","author":"Prader","year":"1989","journal-title":"Helv Paediatr Acta Suppl."},{"issue":"1","key":"2021122116304782200_CIT0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.73.1.17","article-title":"Cross sectional stature and weight reference curves for the UK, 1990","volume":"73","author":"Freeman","year":"1995","journal-title":"Arch Dis Child."},{"issue":"9832","key":"2021122116304782200_CIT0016","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet."},{"issue":"4","key":"2021122116304782200_CIT0017","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2265.2008.03484.x","article-title":"Does preterm birth influence the response to growth hormone treatment in short, small for gestational age children?","volume":"70","author":"de Kort","year":"2009","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"3","key":"2021122116304782200_CIT0018","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society","volume":"92","author":"Clayton","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122116304782200_CIT0019","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1203\/01.PDR.0000148716.71231.81","article-title":"Final height in short children born small for gestational age treated with growth hormone","volume":"57","author":"Dahlgren","year":"2005","journal-title":"Pediatr Res."},{"key":"2021122116304782200_CIT0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-11-38","article-title":"Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database)","volume":"11","author":"Ranke","year":"2011","journal-title":"BMC Med Inform Decis Mak."},{"issue":"2","key":"2021122116304782200_CIT0021","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2007-1381","article-title":"Prediction model for adult height of small for gestational age children at the start of growth hormone treatment","volume":"93","author":"de Ridder","year":"2008","journal-title":"J Clin Endocrinol Metab."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2457\/41839891\/jcem_105_7_e2457.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/7\/e2457\/41839891\/jcem_105_7_e2457.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T16:41:45Z","timestamp":1640104905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/7\/e2457\/5849460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,17]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,1,17]]},"published-print":{"date-parts":[[2020,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa203","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,7]]},"published":{"date-parts":[[2020,1,17]]}}}